MDCX Stock Analysis: Buy, Sell, or Hold?
MDCX - Medicus Pharma Ltd. Common Stock
$0.37
-0.04 (-8.68%)
▼
5d:
-19.09%
30d:
+16.31%
90d:
-10.1%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 10, 2026
26d
Get Alerted When MDCX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MDCX is down 19.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MDCX is down 19.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MDCX is currently trading at $0.37, which is considered fair relative to its 30-day fair value range of $0.35 to $0.45.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.40. Short-term momentum is weak, with the stock down 8.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.67 (+1422.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDCX is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.40. Short-term momentum is weak, with the stock down 8.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.67 (+1422.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.35 -
$0.45
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.7%)
- BULLISH: Trading 1422.5% below Wall St target ($5.67)
- WARNING: Recommendation downgraded due to -19.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.35 -
$0.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.29
Resistance Level
$0.40
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.95
Wall Street Target
$5.67
(+1422.5%)
Share & Embed Analysis
Last updated: July 14, 2026 9:01 AM ET
Data refreshes hourly during market hours. Next update: 10:01 AM
Data refreshes hourly during market hours. Next update: 10:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDCX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1240 | 58 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 64 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$263 | 59 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$223 | 59 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$356 | 56 HOLD |
